PLD2 |
PLD2: Phospholipase D2 |
GAPD |
GAPDH, GAPD, CDABP0047, OK/SW-cl.12: Glyceraldehyde-3-phosphate dehydrogenase |
3.202 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
3.202 |
Evidence |
|
UNG |
IPI00011069 |
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
3.202 |
Evidence |
|
FER1L3 |
FER1L3, KIAA1207, MYOF: Myoferlin |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
3.202 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
HDAC2 |
HDAC2: Histone deacetylase 2 |
3.202 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
DPYSL2 |
DPYSL2, CRMP2: Dihydropyrimidinase-related protein 2 |
3.202 |
Evidence |
|
EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
3.202 |
Evidence |
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
HDLBP |
HDLBP, HBP, VGL: Vigilin |
3.202 |
Evidence |
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
MAP2K4 |
MAP2K4, JNKK1, MKK4, PRKMK4, SERK1: Dual specificity mitogen-activated protein k |
3.202 |
Evidence |
|
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
3.202 |
Evidence |
|
PLD1 |
PLD1: Phospholipase D1 |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
3.202 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
3.202 |
Evidence |
|
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.202 |
Evidence |
|
PLD2 |
PLD2: Phospholipase D2 |
CCT4 |
CCT4, CCTD, SRB: T-complex protein 1 subunit delta |
3.202 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
USP47 |
USP47: Ubiquitin carboxyl-terminal hydrolase 47 |
3.202 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
3.202 |
Evidence |
|
CCNB1 |
Cyclin B1 |
GIT1 |
GIT1: ARF GTPase-activating protein GIT1 |
3.202 |
Evidence |
|
MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
3.202 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
SNF1LK2 |
SNF1LK2, KIAA0781, QIK: Serine/threonine-protein kinase SNF1-like kinase 2 |
3.202 |
Evidence |
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
3.202 |
Evidence |
|
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.202 |
Evidence |
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
3.202 |
Evidence |
|
ENO2 |
ENO2: Gamma-enolase |
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
3.202 |
Evidence |
|
SMAD4 |
SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
3.202 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
PPIA |
PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A |
3.202 |
Evidence |
|